WO2005063177A1 - Zwei-oder mehrphasige kosmetische mittel mit verbessertem reversiblen mischungs-und entmischungsverhalten - Google Patents
Zwei-oder mehrphasige kosmetische mittel mit verbessertem reversiblen mischungs-und entmischungsverhalten Download PDFInfo
- Publication number
- WO2005063177A1 WO2005063177A1 PCT/EP2004/012906 EP2004012906W WO2005063177A1 WO 2005063177 A1 WO2005063177 A1 WO 2005063177A1 EP 2004012906 W EP2004012906 W EP 2004012906W WO 2005063177 A1 WO2005063177 A1 WO 2005063177A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acyl
- acid
- salts
- glutamic acid
- alcohol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/04—Preparations for permanent waving or straightening the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/03—Liquid compositions with two or more distinct layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
Definitions
- the invention relates to a process for the permanent deformation of keratin fibers, in particular human hair, by reductive cleavage and renewed oxidative formation of disulfide bonds in keratin, and to multiphase agents suitable for this process with improved mixing and segregation behavior.
- the permanent deformation of keratin fibers is usually carried out in such a way that the fiber is mechanically deformed and the deformation is determined by suitable aids.
- the fiber Before and / or after this deformation, the fiber is treated with the aqueous preparation of a keratin-reducing substance and, after an exposure time, rinsed with water or an aqueous solution.
- the fiber is then treated with the aqueous preparation of an oxidizing agent. After an exposure time, this is also rinsed out and the fiber is freed from the mechanical deformation aids (curlers, papillots).
- the aqueous preparation of the keratin-reducing agent is usually made alkaline so that, on the one hand, a sufficient proportion of the thiol functions are deprotonated and, on the other hand, the fiber swells and in this way a deep penetration of the keratin-reducing substance into the fiber is made possible.
- the keratin-reducing substance cleaves a part of the disulfide bonds of the keratin to -SH groups, so that the peptide crosslinking is loosened and, as a result of the tension in the fiber due to the mechanical deformation, the keratin structure is reoriented.
- a known method of this type is permanent wave treatment of human hair. This can be used both for producing curls and waves in straight hair and for straightening curly hair.
- a negative side effect of the permanent waving of the hair is often embrittlement and dulling of the hair.
- Other properties such as wet and dry combability, feel, smoothness, softness, gloss and tear resistance are also affected in an undesirable manner.
- a corresponding modification of the reducing solution generally leads to unsatisfactory wave outputs.
- additives such as structurants, polymers, film formers and crosslinking resins or the neutral to slightly acidic setting of the preparation can reduce the damage to the hair, but the structure of the hair remains more or less weakened.
- the nourishing treatment of the hair by further post-treatments can improve the hair properties again, but requires additional time and generally the use of at least one other agent.
- the homogeneous mixture of the phases before use and the reversibility of this mixture are crucial.
- the mixing and demixing behavior of the phases after use is unsatisfactory. This is particularly the case when the mixing and demixing process is carried out several times complete mixing or, in particular, separation of the phases is not guaranteed satisfactorily.
- the invention therefore relates to a process for the permanent deformation of keratin fibers, in which the fiber is treated with an aqueous preparation of a keratin-reducing substance before and / or after mechanical deformation, rinsed after a contact time with a first rinse, then with an aqueous preparation Oxidizing agent fixed and also rinsed after an exposure time and optionally aftertreated, characterized in that at least one of the two aqueous preparations or the first rinse is in the form of a two- or multi-phase system, the at least one oil component and as an emulsifier at least one N-acyl-glutamic acid or contains their salts and is reversibly converted into a homogeneous system by mechanical movement for application to the fiber.
- the corrugating agent, the intermediate rinse and / or the fixing agent is formulated in the form of a two- or multi-phase system.
- Two- and multi-phase systems used according to the invention are systems in which there are at least two separate, continuous phases. Examples of such systems are preparations which have the following phases:
- the agents used in the process according to the invention and having two or more phases have their full effect only if they are applied to the keratin fiber in a homogeneous form.
- the means by mechanical action for. B. simple shaking of the container containing them by hand, reversibly converted into homogeneous systems.
- this homogeneous state must be maintained for a sufficient time before the individual phases form again.
- this homogeneous state is stable for at least 20 seconds, in particular at least 30 seconds, before a boundary layer and thus the formation of the individual phases can be recognized again by the viewer.
- the reversible mixture of the phases has taken place by segregation, so that the initial state is reached again while the two-phase or multiphase system is retained.
- the two-phase and multiphase systems used according to the invention necessarily contain at least one oil component.
- Oil components suitable according to the invention are in principle all oils and fatty substances as well as their mixtures with solid paraffins and waxes.
- Preferred oil components are those whose solubility in water at 20 ° C. is less than 1% by weight, in particular less than 0.1% by weight.
- the melting point of the individual oil or fat components is preferably below about 40 ° C.
- Oil components that are at room temperature, i.e. H. are liquid below 25 ° C, can be particularly preferred according to the invention.
- the oil components are preferably in the weight ratio range to the remaining components from 1 to 200 to 1 to 1, particularly preferably from 1 to 40 to 1 to 1, whole particularly preferably from 1 to 20 to 1 to 3, contained in the agents of the process according to the invention.
- a preferred group of oil components are vegetable oils.
- vegetable oils examples include apricot kernel oil, avocado oil, sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach seed oil and the liquid components of coconut oil.
- triglyce oils such as the liquid portions of beef tallow and synthetic triglyce oils are also suitable.
- liquid paraffin oils and synthetic hydrocarbons and di-alkyl ethers with a total of between 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as, for example, di-n-octyl ether, di-n -decyl ether, di-n-nonyl ether, di-n-undecyl ether, di-n-dodecyl ether, n-hexyl-n-octyl ether, n-octyl-n-decyl ether, n-decyl-n-undecyl ether, n-undecyl-n -dodecyl ether and n-hexyl-n-undecyl ether and di-tert-butyl ether, di-isopentyl ether, di-3-ethyldecyl ether, tert
- the compounds are available as commercial products 1, 3-di- (2-ethyl-hexyl) -cyclohexane (Cetiol ® S), and di-n-octyl ether (Cetiol ® OE) may be preferred.
- Oil components which can likewise be used according to the invention are fatty acid and fatty alcohol esters.
- the monoesters of fatty acids with alcohols having 3 to 24 carbon atoms are preferred.
- This group of substances concerns the products of the esterification of fatty acids with 8 to 24 carbon atoms such as, for example, caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, Petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures, the z.
- alcohols such as isopropyl alcohol, glycerol, capronic alcohol, caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, Isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, LinoJyla alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, Erucyl alcohol and brassidyl alcohol and their technical mixtures, the z.
- alcohols such as isopropyl alcohol, glycerol, capronic alcohol, caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, Isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol
- the invention particularly preferably isopropyl myristate, isononanoic acid C16-18 alkyl ester (Cetiol ® SN), stearic acid-2-ethylhexyl ester (Cetiol ® 868), cetyl oleate, glycerol tricaprylate, cocofatty alcohol caprate / caprylate and n-butyl stearate.
- dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate as well as diol esters such as ethylene glycol dioleate, ethylene glycol di-isotridecanoate and propylene glycol di (2-ethylhexanoate), propylene glycol di-isostearate, propylene glycol di-pelargonate, butanediol di-isostearate and neopentyl glycol di-capylate are oil components which can be used according to the invention, and also complex esters such as, for. B. the diacetyl glycerol monostearate.
- hydrophobic components which can preferably be used according to the invention are also silicone oils, in particular dialkyl and alkylarylsiloxanes, such as, for example, dimethylpolysiloxane and methylphenylpolysiloxane, and also their alkoxylated and quaternized analogs and cyclic siloxanes.
- silicone oils in particular dialkyl and alkylarylsiloxanes, such as, for example, dimethylpolysiloxane and methylphenylpolysiloxane, and also their alkoxylated and quaternized analogs and cyclic siloxanes.
- silicones examples include the products sold by Dow Corning under the names DC 190, DC 200 and DC 1401 and the commercial products DC 344 and DC 345 from Dow Corning, Q2-7224 (manufacturer: Dow Corning; a stabilized trimethylsilylamodimethicone), Dow Corning ® 929 emulsion (containing a hydroxylamino-modified silicone, which is also known as amodimethicone), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® -Quat 3270 and 3272 (manufacturer: Th. Goldschmidt; di-quaternary polydimethylsiloxanes, Quatemium-80).
- silicone oils with a kinematic viscosity of up to 50,000 cSt, measured at 25 ° C. are preferred. Silicone oils with kinematic viscosities up to 10,000 cSt measured at 25 ° C are very particularly preferred.
- the viscosities are determined using the ball drop method in accordance with the "British Standard 188" method. Comparable values are obtained with the manufacturer's test instructions analogous to the "British Standard 188", for example the "CTM 0577” from Dow Corning Corporation.
- cyclic siloxanes such as, for example, the products Dow Corning® 344, Dow Corning ® 345, Dow Corning ® 244, Dow Corning ® 245 or Dow Corning ® 246 with kinematic viscosities of up to 10,000 cSt at 25 ° C determined according to the manufacturer's instructions.
- N-acyl-glutamic acid or the salts thereof which are mandatory as emulsifiers in the two-phase or multi-phase agents of the method according to the invention or their salts are particularly preferably used in combination with a silicone oil as an oil component in the two-phase or multi-phase agents of the method according to the invention.
- oil components which can be used according to the invention are also dialkyl carbonates, as are described in detail in DE-OS 197 101 54, to which reference is expressly made.
- Dioctyl carbonates, especially di-2-ethylhexyl carbonate, are preferred oil components in the context of the present invention.
- the N-acyl-glutamic acid contained in the two-phase or multi-phase centers in the process according to the invention is a condensation product of glutamic acid with saturated or mono- or polyunsaturated fatty acids or fatty acid mixtures, such as, for example, oleic acid, myristic acid, lauric acid, capric acid, palmitic acid, undecylenic acid, coconut fatty acid and abietic acid.
- These condensation products can also be in the form of salts, in particular sodium, potassium, magnesium and triethanolamine salts.
- the N-acyl-glutamic acid is selected from N- (Cg-C 30 ) -acyl-glutamic acid and its salts.
- Glutamic acids N-acyl examples of commercially available invention or their salts are Plantapon ® ACG 35 (Cognis Germany), Protelan ® AG 8 (Zschimmer & Schwarz Italiana), Protelan ® AG 100 (Zschimmer & Schwarz Italiana), Protelan ® AG 110 / N (Zschimmer & Schwarz Italiana), Sepifeel One ® (Seppic), Protelan ® AG 89 / K (Zschimmer & Schwarz Italiana), Amisoft ® ECS-22 (Ajinomoto USA), Amisoft ® LS-22 (Ajinomoto USA), Amisoft ® HS-22 (Ajinomoto USA) and glutamates ® MK-11 (Ajinomoto USA).
- the agents preferably contain N-acyl-glutamic acid or its salts in an amount of 0.05 to 10% by weight, in particular 0.1 to 2% by weight, based on the weight of the agent.
- the N-acyl-glutamic acid or its salts are preferably present in the compositions in a weight ratio to the oil component of 1 to 200 to 1 to 7, in particular 1 to 100 to 1 to 5.
- miscible alcohols in addition to the oil components mentioned, only limited miscible alcohols can be used with water.
- “Miscible with water” means those alcohols which are not more than 10% by weight soluble in water at 20 ° C., based on the mass of water.
- triols and in particular diols have proven to be particularly suitable according to the invention.
- Alcohols having 4 to 20, in particular 4 to 10, carbon atoms can be used according to the invention.
- the alcohols used according to the invention can be saturated or unsaturated and linear, branched or cyclic.
- Used for the purposes of the invention are, for example, 1-butanol, cyclohexanol, pentanol-1, decanol, octanol, octenol, dodecenol, decenol, octadienol, dodecadienol, Decadienol, oleyl alcohol, erucyl alcohol, ricinol alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, Myristyialkohol, arachidyl , Caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol, and their Guerbet alcohols, this list being intended to be exemplary and not limiting.
- the fatty alcohols derive from preferably natural fatty acids, and it can usually be assumed that they are obtained from the esters of the fatty acids by reduction.
- suitable according to the invention are those fatty alcohol cuts which are produced by reducing naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols.
- Preferred alcohols according to the invention are 2-ethyl-hexanedio!
- the teaching according to the invention also includes those embodiments of the method according to the invention in which the multiphase agent is prepared from two or more separately prepared starting preparations only immediately before use. This embodiment can be preferred for extremely incompatible components.
- the wellotion is formulated in the form of the two-phase or multiphase system mentioned above. It has surprisingly been found that waving lotions formulated in this way produce a significantly increased wave effect with the same amount of the respective keratin-reducing components. Analogously, the wave power achieved with a wellotion not formulated according to the invention can be achieved with a wellotion formulated according to the invention while significantly reducing the proportion of the keratin-reducing substance, and thus protecting the hair and scalp.
- agents are used in the course of a process for the permanent deformation of keratin fibers either to carry out the reducing step, to carry out the oxidizing step or to rinse after carrying out the reducing step and can in principle contain all the constituents customary for these agents, provided that the conditions according to the invention (presence of Two- or multi-phase system and the short-term miscibility) are given.
- a second object of the invention is therefore a means for carrying out the reducing step of a process for the permanent shaping of keratin fibers containing a keratin-reducing substance and conventional constituents, characterized in that it is in the form of a two- or multi-phase system which contains at least one oil component and as an emulsifier Contains N-acyl-glutamic acid or its salts and which can be reversibly converted into a homogeneous system by mechanical movement.
- the waving agents according to the invention necessarily contain the mercaptans known as keratin-reducing substances.
- Such compounds are, for example, thioglycolic acid, thiolactic acid, thio malic acid, mercaptoethanesulfonic acid and their salts and esters, cysteamine, cysteine, multicolored salts and salts of sulfurous acid.
- the alkali metal or ammonium salts of thioglycolic acid and / or thiolactic acid and the free acids are preferred. These are preferably used in the waving agents in concentrations of 0.5 to 1.0 mol / kg at a pH of 5 to 12, in particular from 7 to 9.5. To adjust this pH, the waving agents according to the invention usually contain alkalizing agents such as ammonia, alkali and ammonium carbonates and hydrogen carbonates or organic amines such as monoethanolamine.
- the corrugation lotions according to the invention can contain corrugation-strengthening components, for example • heterocyclic compounds such as imidazole, pyrrolidine, piperidine, dioxolane, dioxane, morpholine and piperazine as well as derivatives of these compounds such as the C-
- Preferred substituents which can be positioned both on carbon atoms and on nitrogen atoms of the heterocyclic ring systems are methyl, ethyl, ⁇ -hydroxyethyl and ⁇ -aminoethyl groups.
- heterocyclic compounds preferred according to the invention are, for example, 1-methylimidazole, 2-methylimidazole, 4 (5) -methylimidazole, 1, 2-dimethylimidazole, 2-ethylimidazole, 2-isopropylimidazole, N-methylpyrrolidone, 1-methylpiperidine, 4-methylpiperidine, 2-ethylpiperidine, 4-methylmorpholine, 4- (2-hydroxyethyl) morpholine, 1-ethylpiperazine, 1- (2-hydroxyethyl) piperazine, 1- (2-aminoethyl) piperazine.
- Imidazole derivatives preferred according to the invention are biotin, hydantoin and benzimidazole. Imidazole is very particularly preferred.
- Amino acids such as arginine, citrulline, histidine, omithine and lysine in particular.
- the amino acids can be used both as free amino acids and as salts, e.g. B. be used as hydrochlorides.
- oligopeptides consisting of an average of 2-3 amino acids, which have a high proportion (> 50%, in particular> 70%) of the amino acids mentioned, have also proven to be usable according to the invention.
- Arginine and its salts and arginine-rich oligopeptides are particularly preferred according to the invention.
- Diols such as 2-ethyl-1, 3-hexanediol, 1, 3-butanediol, 1, 4-butanediol, 1, 2-propanediol, 1, 3-propanediol, neopentyl glycol and ethylene glycol.
- 1,3-diols in particular 2-ethyl-1, 3-hexanediol and 1, 3-butanediol, have proven to be particularly suitable.
- the waving-strengthening compounds can be contained in the waving lotions according to the invention in amounts of 0.5 to 5% by weight, based on the total waving lotions. Amounts of 1 to 4% by weight, in the case of the diols 0.5 to 3% by weight, have proven to be sufficient, which is why these amounts are particularly preferred.
- a third subject of the invention is a means for carrying out the oxidizing step of a process for the permanent shaping of keratin fibers containing an oxidizing agent and conventional constituents, characterized in that it is in the form of a two- or multi-phase system which has at least one oil component and at least one as an emulsifier Contains N-acyl-glutamic acid or its salts and which can be reversibly converted into a homogeneous system by mechanical movement.
- oxidizing agents e.g. As sodium bromate, potassium bromate, hydrogen peroxide, and the usual stabilizers for stabilizing aqueous hydrogen peroxide preparations.
- the pH of such aqueous H2O2 preparations which is usually about 0.5 to 15 wt .-%, ready to use in the
- H 2 O 2 Usually containing about 0.5 to 3% by weight of H 2 O 2 is preferably 2 to 6, in particular
- Bromate-based fixatives usually contain the bromates in concentrations of 1 to 10% by weight and the pH of the solutions is adjusted to 4 to 7.
- Fixing agents based on enzymes e.g. peroxidases which contain no or only small amounts of oxidizing agents, in particular H2O2, are also suitable.
- a fourth object of the invention is a rinsing agent after carrying out the reducing step of a process for the permanent shaping of keratin fibers containing conventional constituents, characterized in that it is in the form of a two-phase or multiphase system which comprises at least one oil component and at least one N-acyl as emulsifier contains glutamic acid or its salts and which can be reversibly converted into a homogeneous system by mechanical movement.
- oil components and N-acyl-glutamic acids or their salts are preferred to use in the above-mentioned agents according to the invention and in the embodiments mentioned in the first subject of the invention.
- N-acyl-glutamic acid or its salts it may be preferred according to the invention to use N-acyl-glutamic acid or its salts as the only emulsifier in the compositions according to the invention in one embodiment of the compositions according to the invention. It can also be in the frame In this embodiment, it may be preferred to use the N-acyl-glutamic acid or its salts as the only N-acyl-amino acid in the agents according to the invention.
- the agents according to the invention contain a nourishing active ingredient selected from protein hydrolyzates and their derivatives.
- Suitable protein hydrolyzates are in particular elastin, collagen, keratin, milk protein, silk protein, soy protein, almond protein, pea protein, potato protein, oat protein, corn protein and wheat protein hydrolyzates. Products based on plants can be preferred according to the invention.
- Suitable derivatives are in particular quaternized protein hydrolyzates.
- Examples of this class of compounds are sold under the names Lamequat® ® L (CTFA name: Lauryidimonium hydroxypropylamino Hydrolyzed Animal Protein; Grunau) products present, Croquat ® WKP and Gluadin® ® WQ on the market. The latter product, which is based on plants, may be preferred.
- the protein derivatives are preferably present in the agents according to the invention in amounts of 0.1 to 10% by weight, based on the total amount of the agent. Amounts of 0.1 to 5% by weight are preferred.
- the agents according to the invention preferably also contain at least one conditioning active ingredient.
- Cationic polymers are preferred as conditioning agents. These are usually polymers that contain a quaternary nitrogen atom, for example in the form of an ammonium group.
- Preferred cationic polymers are, for example quaternized cellulose derivatives, as are commercially available under the names Celquat ® and Polymer JR ® .
- the compounds Celquat ® H 100, Celquat ® L 200 and Polymer JR ® 400 are preferred quaternized cellulose derivatives.
- Merquat ® 100 Poly (dimethyldiallylammonium chloride)
- Merquat ® 550 dimethyl-diallylammo niumchlorid-acrylamide copolymer
- Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoacrylate and methacrylate such as, for example, vinylpyrrolidone-dimethylaminomethacrylate copolymers quaternized with diethyl sulfate.
- Such compounds are commercially available under the names Gafquat ® 734 and Gafquat ® 755.
- Vinylimidazoliniummethochlorid vinylpyrrolidone copolymers such as those sold under the name Luviquat ®, quaternized polyvinyl alcohol, as well as those known under the designations Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 polymers having quaternary nitrogen atoms in the polymer main chain.
- Ampho-polymers are also suitable as conditioning agents.
- Ampho-polymers are amphoteric polymers, ie polymers which contain both free amino groups and free -COOH or SO H groups in the molecule and are capable of forming internal salts, zwitterionic polymers which contain quaternary ammonium groups and -COO in the molecule " - or -S ⁇ 3 ⁇ groups contain, and summarized such polymers that contain -COOH or S ⁇ 3H groups and quaternary ammonium groups.
- amphopolymer usable according to the invention is the acrylic resin available under the name Amphomer ® , which is a copolymer of tert Butylaminoethyl methacrylate, N- (1, 1,3,3-tetramethylbutyl) acrylamide and two or more monomers from the group consisting of acrylic acid, methacrylic acid and their simple esters unsaturated carboxylic acids (e.g. acrylic and methacrylic acid), cationically derivatized unsaturated carboxylic acids (e.g.
- the cationic or amphoteric polymers are preferably present in the preparations according to the invention in amounts of 0.1 to 5% by weight, based on the entire preparation.
- conditioning agents are silicone gums, such as the commercial product Fancorsil ® LIM-1, and anionic silicones, such as the product Dow Corning ® 1784.
- Examples of the cationic surfactants which can be used as conditioning active substances in the agents according to the invention are, in particular, quaternary ammonium compounds.
- Ammonium halides in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, for.
- esters such as for example those sold under the trade names Dehyquart ® and Stepantex ® methyl hydroxyalkyl- dialkoyloxyalkyl methosulfates used.
- alkylamidoamines especially fatty acid amidoamines such as the stearylamidopropyldimethylamine available under the name Tego Amid ® S 18, are notable for their good biodegradability.
- the individual phases may be dyed with dyes in order to achieve a particularly good visual appearance of the agent.
- This Dyes are preferably only soluble in the aqueous or only in at least one non-aqueous phase in an amount which makes a corresponding coloring appear visible to the viewer. It is also possible to color both the nonaqueous and the aqueous phase with different dyes, preferably in different colors. However, staining a non-aqueous phase alone is preferred.
- ampholytic surfactants such as N-alkylglycine, N-alkylpropionic acid, N-alkylaminobutyric acid, N-alkyliminodipropionic acid, N-hydroxyethyl-N-alkylamidopropylglycine, N-alkyltaurine, N-alkylsarcosine, 2-alkylaminopropionic acid and alkylaminoacetic acid.
- nonionic surfactants such as adducts of 2 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide with linear fatty alcohols with 8 to 22 C atoms, with fatty acids with 12 to 22 C atoms and with alkylphenols with 8 to 15 C atoms in the alkyl group, C - ⁇ - C ⁇ fatty acid mono- and d-diesters of adducts of 1 to 30 moles of ethylene oxide with glycerol, C8-C22 alkyl mono- and oligoglycosides and their ethoxylated analogues as well as adducts of 5 to 60 moles of ethylene oxide with castor oil and hardened castor oil, nonionic polymers such as, for example, vinylpyrrolidone / vinyl acrylate copolymers, polyvinylpyrrolidone and vinylpyrrolidone / vinyl acetate copolymers, anionic polymers such as polyacryl
- Ethoxylated fatty alcohols in particular those with limited homolog distribution as they are, for example, as a commercial product under the name Arlypon ® F (Henkel) on the market, alkoxylated methyl glucoside, such as the product Glucamate ® DOE 120 (Amerchol), and ethoxylated Propylenglykolester, such as the product Antil ® 141 (Goldschmidt) may be preferred organic thickeners.
- Structurants such as glucose and maleic acid, hair-conditioning compounds such as phospholipids, for example soy lecithin, egg lecithin and cephalins, perfume oils, solubilizers such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerin, diethylene glycol and ethoxylated triglycerides, and fatty alcohol such as antioxidants and their derivatives such as ethoxylated antioxidants and their derivatives , Piroctone Olamine and Zinc Omadine, active ingredients such as bisabolol, allantoin, panthenol, niacinmid, tocopherol and plant extracts, light stabilizers, consistency enhancers such as sugar esters, polyol esters or polyol alkyl ethers, fats and waxes such as walnut, beeswax, montan wax, paraffins, esters, glycerides and fatty alcohols, Fatty acid alkanolamide
- Waving agent (2 phases) 1 2 3 (according to the invention) aqueous phase 1
- Ammonium thioglycolate (71% in water) 16.0 16.0 16.0
- each cylinder was subjected to 5 mixing-demixing cycles.
- Each wave agent was shaken 25 times in the cylinder per cycle and then left to stand for 5 minutes to separate. After the fifth and final mixing process, the mixture was left to stand for 30 minutes to separate. The mixing and demixing behavior of the wave agents was assessed.
- the 2-phase corrugating agent 1 according to the invention could always be converted into a homogeneous mixture by 5 mixing-demixing cycles and therefore has an excellent demixing behavior with regression of the initial state.
- the 2-phase corrugating agent 2 not according to the invention could be converted into a homogeneous mixture in the 5 mixing-demixing cycles, but an incomplete phase separation took place. The initial state of the multi-phase corrugating agent 2 was therefore not restored.
- the wave agent 3 not according to the invention could not be converted into a homogeneous mixture.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004308057A AU2004308057A1 (en) | 2003-12-19 | 2004-11-13 | Dual or multiple phase cosmetic agent with improved reversible mixing and separation behaviour |
EP04797886A EP1696863B1 (de) | 2003-12-19 | 2004-11-13 | Zwei-oder mehrphasige kosmetische mittel mit verbessertem reversiblen mischungs-und entmischungsverhalten |
DE502004008458T DE502004008458D1 (de) | 2003-12-19 | 2004-11-13 | Zwei-oder mehrphasige kosmetische mittel mit verbessertem reversiblen mischungs-und entmischungsverhalten |
US11/471,103 US20070020214A1 (en) | 2003-12-19 | 2006-06-19 | Dual or multiple phase cosmetic agent with improved reversible mixing and separation behavior |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10360688.2 | 2003-12-19 | ||
DE10360688A DE10360688A1 (de) | 2003-12-19 | 2003-12-19 | Zwei- oder mehrphasige kosmetische Mittel mit verbessertem reversiblen Mischungs- und Entmischungsverhalten |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/471,103 Continuation US20070020214A1 (en) | 2003-12-19 | 2006-06-19 | Dual or multiple phase cosmetic agent with improved reversible mixing and separation behavior |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005063177A1 true WO2005063177A1 (de) | 2005-07-14 |
WO2005063177A8 WO2005063177A8 (de) | 2006-05-04 |
Family
ID=34673047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/012906 WO2005063177A1 (de) | 2003-12-19 | 2004-11-13 | Zwei-oder mehrphasige kosmetische mittel mit verbessertem reversiblen mischungs-und entmischungsverhalten |
Country Status (6)
Country | Link |
---|---|
US (1) | US20070020214A1 (de) |
EP (1) | EP1696863B1 (de) |
AT (1) | ATE413858T1 (de) |
AU (1) | AU2004308057A1 (de) |
DE (2) | DE10360688A1 (de) |
WO (1) | WO2005063177A1 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101299987B (zh) * | 2005-11-01 | 2014-05-07 | 宝洁公司 | 包含稳定香料组合物的多相个人护理组合物 |
EP2135596B1 (de) | 2007-04-17 | 2018-02-21 | Kao Corporation | Haarpflegezusammensetzungen |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1797861A1 (de) | 2005-12-16 | 2007-06-20 | KPSS-Kao Professional Salon Services GmbH | Zusammensetzung zur dauerhaften Verformung des menschlichen Haares |
EP2011543A1 (de) * | 2007-06-26 | 2009-01-07 | KPSS-Kao Professional Salon Services GmbH | Zusammensetzung zur dauerhaften Verformung des menschlichen Haares |
EP2011479A1 (de) * | 2007-06-26 | 2009-01-07 | KPSS-Kao Professional Salon Services GmbH | Zusammensetzung zur dauerhaften Verformung des menschlichen Haares |
EP2011478A1 (de) * | 2007-06-26 | 2009-01-07 | KPSS-Kao Professional Salon Services GmbH | Zusammensetzung zur dauerhaften Verformung des menschlichen Haares |
EP2177245A1 (de) * | 2008-10-20 | 2010-04-21 | KPSS-Kao Professional Salon Services GmbH | Zusammensetzung zur dauerhaften Verformung des menschlichen Haares |
EP2177203A1 (de) * | 2008-10-20 | 2010-04-21 | KPSS-Kao Professional Salon Services GmbH | Haarfärbezusammensetzungen und Zusammensetzung zur dauerhaften Verformung von Haaren |
EP2177206A1 (de) * | 2008-10-20 | 2010-04-21 | KPSS-Kao Professional Salon Services GmbH | Zusammensetzung zur dauerhaften Verformung des menschlichen Haares |
US20110038910A1 (en) * | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
DE102009047528A1 (de) * | 2009-12-04 | 2011-06-09 | Henkel Ag & Co. Kgaa | Verwendung von Esteröl in Verfahren zur permanenten Haarumformung |
KR101368829B1 (ko) * | 2011-03-08 | 2014-03-03 | 소망화장품주식회사 | 일욕식 퍼머넌트 웨이브용 및 스트레이트너용 용제 조성물 |
WO2023039780A1 (en) * | 2021-09-16 | 2023-03-23 | Beiersdorf Ag | Bi-PHASE MAKE-UP REMOVER |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994004125A1 (en) * | 1992-08-24 | 1994-03-03 | Revlon Consumer Products Corporation | Hair dye preparations and associated methods |
WO1999058099A2 (de) * | 1999-07-03 | 1999-11-18 | Hans Schwarzkopf Gmbh & Co. Kg | Verfahren zur dauerhaften verformung keratinischer fasern und mittel |
WO2002015849A2 (en) * | 2000-08-22 | 2002-02-28 | Unilever Plc | A separating multi-phase personal wash composition in a transparent or translucent package |
WO2002067881A2 (de) * | 2001-02-28 | 2002-09-06 | Hans Schwarzkopf Gmbh & Co. Kg | Verfahren zur dauerhaften verformung keratinischer fasern und mittel |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19854352A1 (de) * | 1998-11-25 | 2000-05-31 | Clariant Gmbh | Haarbehandlungsmittel enthaltend Oligoester |
-
2003
- 2003-12-19 DE DE10360688A patent/DE10360688A1/de not_active Withdrawn
-
2004
- 2004-11-13 WO PCT/EP2004/012906 patent/WO2005063177A1/de active Application Filing
- 2004-11-13 AT AT04797886T patent/ATE413858T1/de active
- 2004-11-13 EP EP04797886A patent/EP1696863B1/de not_active Not-in-force
- 2004-11-13 AU AU2004308057A patent/AU2004308057A1/en not_active Abandoned
- 2004-11-13 DE DE502004008458T patent/DE502004008458D1/de active Active
-
2006
- 2006-06-19 US US11/471,103 patent/US20070020214A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994004125A1 (en) * | 1992-08-24 | 1994-03-03 | Revlon Consumer Products Corporation | Hair dye preparations and associated methods |
WO1999058099A2 (de) * | 1999-07-03 | 1999-11-18 | Hans Schwarzkopf Gmbh & Co. Kg | Verfahren zur dauerhaften verformung keratinischer fasern und mittel |
WO2002015849A2 (en) * | 2000-08-22 | 2002-02-28 | Unilever Plc | A separating multi-phase personal wash composition in a transparent or translucent package |
WO2002067881A2 (de) * | 2001-02-28 | 2002-09-06 | Hans Schwarzkopf Gmbh & Co. Kg | Verfahren zur dauerhaften verformung keratinischer fasern und mittel |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101299987B (zh) * | 2005-11-01 | 2014-05-07 | 宝洁公司 | 包含稳定香料组合物的多相个人护理组合物 |
EP2135596B1 (de) | 2007-04-17 | 2018-02-21 | Kao Corporation | Haarpflegezusammensetzungen |
Also Published As
Publication number | Publication date |
---|---|
EP1696863A1 (de) | 2006-09-06 |
WO2005063177A8 (de) | 2006-05-04 |
DE502004008458D1 (de) | 2008-12-24 |
AU2004308057A1 (en) | 2005-07-14 |
ATE413858T1 (de) | 2008-11-15 |
EP1696863B1 (de) | 2008-11-12 |
DE10360688A1 (de) | 2005-07-14 |
US20070020214A1 (en) | 2007-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE102015221460B4 (de) | Dauerwellverfahren mit verbesserter Pflegeleistung und Wellwirkung | |
US20070020214A1 (en) | Dual or multiple phase cosmetic agent with improved reversible mixing and separation behavior | |
WO2008110223A2 (de) | Wellmittel mit haarfaserstrukturanten | |
EP1191920B1 (de) | Verfahren zur dauerhaften verformung keratinischer fasern und mittel | |
EP1009367B1 (de) | Verwendung einer wirkstoffkombination und mittel zum schutz von keratinischen fasern | |
EP1747045A1 (de) | Verfahren und zusammensetzung zur restrukturierung keratinischer fasern | |
EP3233025A1 (de) | Haarbehandlungsmittel, enthaltend mindestens ein saures protein sowie mindestens ein salz | |
EP1059910A2 (de) | Mittel und verfahren zur behandlung keratinischer fasern | |
WO2012084338A2 (de) | Haarbehandlungsmittel zur glättung keratinhaltiger fasern | |
WO2012163594A2 (de) | Im wesentlichen ammoniak freie wellmittel mit cystein | |
EP1786389B1 (de) | Hautschonende wellmittel | |
WO2011154278A2 (de) | Im wesentlichen ammoniak freie wellmittel | |
DE102008063280A1 (de) | Wellmittel mit Aloe Vera | |
DE102009029183A1 (de) | Dauerwellsystem | |
DE10224248A1 (de) | Kosmetische Mittel mit Protein-Disulfidisomerase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004797886 Country of ref document: EP |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 28/2005 UNDER (71) DELETE "MUELLER, BURKHARD [DE/DE]"; UNDER (72, 75) ADD "MUELLER, BURKHARD [DE/DE]" |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004308057 Country of ref document: AU Ref document number: 11471103 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2004308057 Country of ref document: AU Date of ref document: 20041113 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004308057 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004797886 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11471103 Country of ref document: US |